Published • loading... • Updated
HeraMED Advances US Commercialisation with Positive Lee Health Pilot and Philips Partnership
Summary by sharecafe.com.au
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
HeraMED Advances US Commercialisation with Positive Lee Health Pilot and Philips Partnership
HeraMED Limited (ASX:HMD), a medical data and technology company transforming women’s and maternity care, today released its Q2 FY26 quarterly activities and cashflow report. The company, which provides a platform utilising hardware and software for prenatal and postpartum experiences, reported significant US commercialisation progress. MD & CEO Anoushka Gungadin emphasised advancing key opportunities with Lee Health and Philips during the quart…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
